Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
Tatva Chintan Pharma Chem Limited, a prominent player in the chemicals nec industry, is headquartered in India and operates across various regions, catering to a global clientele. Founded in 1996, the company has established itself as a leader in the production of specialty chemicals, particularly in the fields of pharmaceuticals, agrochemicals, and electronic chemicals.
Tatva Chintan's core offerings include high-quality chemical intermediates and performance chemicals, which are distinguished by their innovative formulations and adherence to stringent quality standards. The company has achieved significant milestones, including recognition for its sustainable practices and commitment to research and development. With a strong market position, Tatva Chintan continues to drive advancements in the chemical sector, making it a trusted partner for industries worldwide.
-21 vs industry average
Tatva Chintan Pharma Chem Limited’s score of 11 is lower than 20% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Chemicals is among the most carbon-intensive industries
The Chemicals industry has reduced its overall emissions by 19% since 2018
Scope 3 accounts for ••• of total emissions.
Tatva Chintan Pharma Chem Limited, a Chemicals company headquartered in India, reported Scope 1 emissions of 7,663,180 kg CO2e and Scope 2 emissions of 15,022,340 kg CO2e for 2025. In 2024, the company's Scope 1 emissions were 6,969,060 kg CO2e and Scope 2 emissions were 15,160,420 kg CO2e. Looking back to 2023, Tatva Chintan Pharma Chem Limited's Scope 1 emissions were approximately 1,055,700 kg CO2e and Scope 2 emissions were about 10,262,920 kg CO2e. For 2022, Scope 1 emissions were around 1,119,850 kg CO2e, and Scope 2 emissions were 13,116,800 kg CO2e. In 2021, the company reported total emissions of 522,620 kg CO2e, although specific Scope 1 and Scope 2 data for that year were not provided. The company has committed to Science Based Targets initiative (SBTi) for near-term reductions.
Access structured emission data, company specific factors and auditable source documents
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
No scope 3 category breakdown has been disclosed yet.


Common questions about Tatva Chintan Pharma Chem Limited’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more